Shanghai GeneSc is a subsidiary of China GeneDx Biotechnology Corporation under China National Pharmaceutical Group Corporation.
GeneSc and Oxford University have reached cooperation on the OXLAMP project of rapid nucleic acid detection technology for COVID-19. It has obtained the exclusive authorization for the use of OXLAMP technology in mainland China and will introduce advanced vitro diagnostic technology from Oxford University through a long-term strategic partnership.
GeneSc focuses on the Research and Development, production and sales of products related to rapid COVID-19 detection. The rapid COVID-19 detection kits produced by GeneSc have been used in Hong Kong Airport and 4 British airports including Heathrow Airport. The detection does not require. One round test time only requires 30 minutes to obtain the results.
The GeneSc rapid test reagent has obtained CE certification and entered the white list of the Ministry of Commerce at the end of 2020.
Company’s Keywords:
biopharmacy, medical instruments, in vitro reagent testing
<6
<
<
<2020
Your request has been submitted successfully.
Own or work here?